A recall by Boston Scientific Corp. of its Ingenio heart devices has been labeled as high-risk class I by the US Food and Drug Administration.
The company recalled the Ingenio family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps) on 3 June. The firm recalled...